Podcast episode 51 (in German)
GLOW (GHK-Cu + BPC-157 + TB-500): the beauty stack fact-checked
August 22, 2026
Two thirds Wolverine stack plus a copper peptide: GLOW combines GHK-Cu, BPC-157 and TB-500 and aims the healing combination at the skin. The hyped beauty stack has clever ingredients, but there is not a single study on the mixture itself.
What it is about
GHK-Cu is a peptide made of 3 amino acids that carries a copper ion; Loren Pickart discovered it in blood plasma in 1973. The skin needs copper for enzymes that cross-link collagen and elastin, scavenge radicals and form pigment, and the peptide delivers it precisely there. BPC-157 contributes new blood vessels, TB-500 makes repair cells mobile; together this adds up to construction workers, access roads and a blueprint. The episode explains where the trend comes from, what users report and why it has made the peptide scene more female. At the end stand a plausible hypothesis that users test on themselves and a well-supported, legal entry point via copper peptide serums.
Key points
- At 20, the GHK-Cu level in the blood is about 200 nanograms per milliliter; by 60, more than half of it has disappeared.
- Gene expression analyses from 2015 show that GHK-Cu alters the activity of around 4,000 genes, predominantly toward repair, collagen and less inflammation; these are cell culture data.
- As a cosmetic ingredient, GHK-Cu has been established for decades and in comparative studies in some cases even beat retinol on wrinkle depth and skin firmness.
- In studies, GHK-Cu prolonged the growth phase of hair follicles; that is why it is found in hair growth serums, and GLOW users often report fuller hair.
- As a report: users describe plumper-looking skin, finer pores and better nails, a first freshness after 2 to 3 weeks and the actual effect after 6 to 8 weeks.
- From 30 onwards, the body’s own collagen production declines by about 1 percent per year; typical GLOW users are therefore in their mid-30s and older.
- There is no published study on the three-way combination; for thymosin beta-4, the parent substance of TB-500, there are at least wound-healing studies in humans.
Where the data stop
The individual components have their data base: GHK-Cu cell and cosmetic data, BPC-157 mainly animal models, TB-500 wound-healing data from the parent substance. The combination as an injection is scientific uncharted territory, and the reports, however numerous and enthusiastic, do not replace a study. None of the three substances is approved as a medicine, as of August 2026, purity is up to the supplier, and the peptides are banned in competitive sport. With the copper peptide, users more often report burning or redness at the injection site, and anything that promotes blood vessel growth and cell migration is off-limits in active cancer.
The route to GHK-Cu with the strongest data and the lowest risk is via serums, often combined with microneedling. Sun protection, sleep and protein do more for the skin than any vial.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on August 22, 2026.
The topic in the database
- The most hyped beauty stack in the peptide scene: the copper peptide GHK-Cu plus the Wolverine duo BPC-157 + TB-500 – goal: skin rejuvenation from within.GLOW (GHK-Cu + BPC-157 + TB-500)
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-09-26.